Early Breast Cancer in Elderly Women Treated with an Aromatase Inhibitor (Letrozole) as Sole Therapy

被引：0
|
作者：
Balakrishnan, A. [1 ]
Ravichandran, D. [1 ]
机构：
[1] Luton & Dunstable Hosp NHS Fdn Trust, Luton, Beds, England
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P6-14-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-14-12
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy
    Chavarri-Guerra, Y.
    Higgins, M. J.
    Szymonifka, J.
    Cigler, T.
    Liedke, P.
    Partridge, A.
    Ligibel, J.
    Come, S. E.
    Finkelstein, D.
    Ryan, P. D.
    Goss, P. E.
    BRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2046 - 2050
  • [32] The effect of the aromatase inhibitor letrozole on lipid parameters in postmenopausal women with metastatic breast cancer. A preliminary report.
    Nicolaides, C
    Elisaf, M
    Bairaktari, E
    Kakaidi, V
    Katsaraki, A
    Pavlidis, N
    ANNALS OF ONCOLOGY, 2000, 11 : 12 - 12
  • [33] Personalizing aromatase inhibitor therapy in patients with breast cancer
    Hamadeh, Issam S.
    Patel, Jai N.
    Rusin, Stephanie
    Tan, Antoinette R.
    CANCER TREATMENT REVIEWS, 2018, 70 : 47 - 55
  • [34] High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy
    Bouvard, B.
    Hoppe, E.
    Soulie, P.
    Georgin-Mege, M.
    Jadaud, E.
    Abadie-Lacourtoisie, S.
    Le Manac'h, A. Petit
    Laffitte, A.
    Levasseur, R.
    Audran, M.
    Chappard, D.
    Legrand, E.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1151 - 1155
  • [35] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
  • [36] Perioperative Aromatase Inhibitor Therapy for Patients with Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (02) : 114 - +
  • [37] Aromatase inhibitor as neoadjuvant hormone therapy for breast cancer
    Kobayashi, N.
    Ito, Y.
    Hikichi, M.
    Miyajima, S.
    Utsumi, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S56 - S57
  • [38] Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer
    Dixon, J. Michael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 453 - 463
  • [39] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Kwan, Marilyn L.
    Yao, Song
    Laurent, Cecile A.
    Roh, Janise M.
    Quesenberry, Charles P., Jr.
    Kushi, Lawrence H.
    Lo, Joan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 523 - 530
  • [40] Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer
    Figg, William D., II
    Cook, Katherine
    Clarke, Robert
    CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1586 - 1587
12345